Related references
Note: Only part of the references are listed.Various aspects of inflammation in heart failure
Mieczyslaw Dutka et al.
HEART FAILURE REVIEWS (2020)
Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis
Hannes Neuwirt et al.
CELL COMMUNICATION AND SIGNALING (2020)
Advances and Challenges in Computational Target Prediction
Dominique Sydow et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Swiss Target Prediction: updated data and new features for efficient prediction of protein targets of small molecules
Antoine Daina et al.
NUCLEIC ACIDS RESEARCH (2019)
The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes
Francesca Iannantuoni et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Mushroom Tyrosinase-Based Enzyme Inhibition Assays Are Not Suitable for Bioactivity-Guided Fractionation of Extracts
Fabian Mayr et al.
JOURNAL OF NATURAL PRODUCTS (2019)
UniProt: a worldwide hub of protein knowledge
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2019)
PubChem 2019 update: improved access to chemical data
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2019)
The Reactome Pathway Knowledgebase
Antonio Fabregat et al.
NUCLEIC ACIDS RESEARCH (2018)
Canagliflozin exerts anti-inflammatory effects by inhibiting intracellular glucose metabolism and promoting autophagy in immune cells
Chenke Xu et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Medicinal chemistry in drug discovery in big pharma: past, present and future
Ian B. Campbell et al.
DRUG DISCOVERY TODAY (2018)
Anti-inflammatory effects of empagliflozin in patients with type 2 diabetes and insulin resistance
Sachiko Hattori
DIABETOLOGY & METABOLIC SYNDROME (2018)
Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
Laween Uthman et al.
FRONTIERS IN PHYSIOLOGY (2018)
The ChEMBL database in 2017
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2017)
Altered CYP19A1 and CYP3A4 Activities Due to Mutations A115V, T142A, Q153R and P284L in the Human P450 Oxidoreductase
Sameer S. Udhane et al.
FRONTIERS IN PHARMACOLOGY (2017)
Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening
Birgit Waltenberger et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Natural Products as Sources of New Drugs from 1981 to 2014
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Counting on natural products for drug design
Tiago Rodrigues et al.
NATURE CHEMISTRY (2016)
Revealing the Macromolecular Targets of Fragment-Like Natural Products
Tiago Rodrigues et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Tools for in silico target fishing
Adria Cereto-Massague et al.
METHODS (2015)
Elucidation of the molecular mechanism and the efficacy in vivo of a novel 1,4-benzoquinone that inhibits 5-lipoxygenase
A. M. Schaible et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Multi-target approach for natural products in inflammation
Andreas Koeberle et al.
DRUG DISCOVERY TODAY (2014)
Revealing the macromolecular targets of complex natural products
Daniel Reker et al.
NATURE CHEMISTRY (2014)
SwissTargetPrediction: a web server for target prediction of bioactive small molecules
David Gfeller et al.
NUCLEIC ACIDS RESEARCH (2014)
SuperPred: update on drug classification and target prediction
Janette Nickel et al.
NUCLEIC ACIDS RESEARCH (2014)
Computational Methods in Drug Discovery
Gregory Sliwoski et al.
PHARMACOLOGICAL REVIEWS (2014)
Shaping the interaction landscape of bioactive molecules
David Gfeller et al.
BIOINFORMATICS (2013)
Computational Drug Repositioning: From Data to Therapeutics
M. R. Hurle et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Histolocalization and physico-chemical characterization of dihydrochalcones: Insight into the role of apple major flavonoids
Matthieu Gaucher et al.
PHYTOCHEMISTRY (2013)
On the origins of drug polypharmacology
Xavier Jalencas et al.
MEDCHEMCOMM (2013)
Large-scale prediction and testing of drug activity on side-effect targets
Eugen Lounkine et al.
NATURE (2012)
SuperTarget goes quantitative: update on drug-target interactions
Nikolai Hecker et al.
NUCLEIC ACIDS RESEARCH (2012)
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2012)
Natural chalcones as dual inhibitors of HDACs and NF-κB
B. Orlikova et al.
ONCOLOGY REPORTS (2012)
Introduction of an Electron Withdrawing Group on the Hydroxyphenylnaphthol Scaffold Improves the Potency of 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2) Inhibitors
Marie Wetzel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2
Denise V. Kratschmar et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Identification of chemically diverse, novel inhibitors of 17β-hydroxysteroid dehydrogenase type 3 and 5 by pharmacophore-based virtual screening
Daniela Schuster et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostatics
M. Stuart Armstrong et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors
Rafaela S. Ferreira et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Quo Vadis, Virtual Screening? A Comprehensive Survey of Prospective Applications
Peter Ripphausen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles
Paul A. Clemons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Structure-based design, synthesis and in vitro characterization of potent 17β-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone
Gabriele Moeller et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
The design of novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors
Nigel Vicker et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Predicting new molecular targets for known drugs
Michael J. Keiser et al.
NATURE (2009)
Accessing target information by virtual parallel screening-The impact on natural product research
Judith M. Rollinger
PHYTOCHEMISTRY LETTERS (2009)
In silico Target Fishing for Rationalized Ligand Discovery Exemplified on Constituents of Ruta graveolens
Judith M. Rollinger et al.
PLANTA MEDICA (2009)
Natural products in drug discovery
Alan L. Harvey
DRUG DISCOVERY TODAY (2008)
Quantifying the relationships among drug classes
Jerome Hert et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Discovery of dapagliflozin: A potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes
Wei Meng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1
Andreas Koeberle et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
SuperPred:: drug classification and target prediction
Mathias Dunkel et al.
NUCLEIC ACIDS RESEARCH (2008)
SuperTarget and Matador: resources for exploring drug-target relationships
Stefan Guenther et al.
NUCLEIC ACIDS RESEARCH (2008)
Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3β-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities
Elika Samandari et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase
Amit V. Pandey et al.
MOLECULAR ENDOCRINOLOGY (2007)
Relating protein pharmacology by ligand chemistry
Michael J. Keiser et al.
NATURE BIOTECHNOLOGY (2007)
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Tiqing Liu et al.
NUCLEIC ACIDS RESEARCH (2007)
Efficient overlay of small organic molecules using 3D pharmacophores
Gerhard Wolber et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
Comparative virtual and experimental high-throughput screening for glycogen synthase kinase-3β inhibitors
T Polgár et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
High-throughput screening with HyperCyt® flow cytometry to detect small molecule formylpeptide receptor ligands
SM Young et al.
JOURNAL OF BIOMOLECULAR SCREENING (2005)
Human rhinovirus 3C protease: Generation of pharmacophore models for peptidic and nonpeptidic inhibitors and their application in virtual screening
T Steindl et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction
TS Rush et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The evolving role of natural products in drug discovery
FE Koehn et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men
K Margiotti et al.
PROSTATE (2002)
Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B
TN Doman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities
JC Le Bail et al.
LIFE SCIENCES (2001)
Cress and potato soluble epoxide hydrolases: Purification, biochemical characterization, and comparison to mammalian enzymes
C Morisseau et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Share Paper
